The 20 Best Nasopharyngeal Carcinoma Doctors Near Me in Flushing, NY

Dev Kamdar is an Otolaryngologist practicing medicine in New Hyde Park, New York. Dr. Kamdar is rated as a Distinguished provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy. Dr. Kamdar is board certified in American Board Of Otolaryngology.

Bhupesh Parashar is a Radiation Oncologist practicing medicine in Forest Hills, New York. Dr. Parashar is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Adult Soft Tissue Sarcoma, Lung Cancer, Pleuropulmonary Blastoma, and Gastrostomy. Dr. Parashar is board certified in American Board Of Radiology/Radiation Oncology.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Justin Tang is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Jana Fox is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Throat Cancer, and Laryngeal Cancer.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Madhur Garg earned his medical degree at King George’s Medical College and completed his residency in radiation oncology at Rush-Presbyterian-St. Luke’s Hospital in Chicago and Montefiore in New York City. He also completed a specialized fellowship at Wayne State University in Detroit. Dr. Garg is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Prostate Cancer, Acoustic Neuroma, and Familial Prostate Cancer.

I strive to provide the best and most current techniques in head and neck surgery. Following my training at the University of Toronto, Cedars Sinai in Los Angeles and Sloan Kettering here in NY, I was appointed as Residency Director at Manhattan Eye Ear Throat Hospital. Since 1987, I have been in private practice in Manhattan and Queens, where I am the Chief of the Head and Neck Service. I have had over 30 years of experience dealing with tumors in this region.My interests include thyroid and parathyroid surgery, salivary gland surgery, cancers of the oral cavity and larynx and the treatment of sinusitis. Nerve monitoring during complex surgery is frequently utilized.This is a solo practice so all patients are seen and treated by myself, both in the office and in the operating room. Dr. Shemen is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Nonsyndromic Hearing Loss, Deafness Hypogonadism Syndrome, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Swallowing Difficulty, and Thyroidectomy. Dr. Shemen is board certified in American Board Of Otolaryngology.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, and Teratocarcinosarcoma.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy. Dr. Frank is board certified in American Board Of Otolaryngology.

Jerry Huo is a General Surgeon practicing medicine in Flushing, New York. Dr. Huo is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Nonsyndromic Hearing Loss, Deafness Hypogonadism Syndrome, Infant Hearing Loss, and DFNB1.

Zhenqing Wu is an Otolaryngologist practicing medicine in Flushing, New York. Dr. Wu is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Trachoma, Laryngitis, Enlarged Adenoids, and Ruptured Eardrum.

Zili He is an Internal Medicine provider practicing medicine in Flushing, New York. Dr. He is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Thrombocytopenia, Angiosarcoma, and Stomach Cancer.

Kee Shum is an Oncologist practicing medicine in Flushing, New York. Dr. Shum is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Stomach Cancer, Angiosarcoma, and Inflammatory Breast Cancer.

Stuart Packer, MD, is a medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer. After graduating magna cum laude from Case Western Reserve University, Dr. Packer received his medical degree from the State University of New York/Downstate Medical Center. He went on to complete a residency in medicine and fellowship in hematology/medical oncology at Duke University Medical Center. Since then Dr. Packer has held clinical and teaching positions at leading cancer centers, including Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and Montefiore Einstein Center for Cancer Care. Dr. Packer is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Throat Cancer, and Laryngeal Cancer.

Enrico Castellucci is a Hematologist practicing medicine in Bronx, New York. Dr. Castellucci is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His clinical expertise encompasses Nasopharyngeal Carcinoma, Laryngeal Cancer, Throat Cancer, Non-Small Cell Lung Cancer (NSCLC), and Bone Marrow Aspiration.

Richard V. Smith, MD, FACS, is Chair, Otorhinolaryngology-Head & Neck Surgery, Professor, Otorhinolaryngology-Head & Neck Surgery, Professor, Surgery and Professor, Pathology at Montefiore Einstein. Dr. Smith’s clinical focus is on head and neck surgery, including transoral robotic and laser surgery for throat and larynx cancer, salivary gland, thyroid and parathyroid surgery. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngectomy, and Parathyroidectomy.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Nephrectomy, and Prostatectomy.